A pediatric gateway initiative for glomerular disease: introducing PIONEER
- 1 March 2021
- journal article
- editorial
- Published by Elsevier in Kidney International
- Vol. 99 (3) , 515-518
Abstract
No abstract availableKeywords
Funding Information
- U.S. Food and Drug Administration
This publication has 6 references indexed in Scilit:
- Ethical Drug Development for Rare Childhood Diseases: When There Are Limited But Promising Data in Adults, How to Choose Between Safety or Efficacy Studies?The American Journal of Bioethics, 2020
- Cardiovascular Disease in Children and Adolescents With Chronic Kidney DiseaseSeminars in Nephrology, 2018
- Systems biology approaches to identify disease mechanisms and facilitate targeted therapy in the management of glomerular diseaseCurrent Opinion in Nephrology and Hypertension, 2018
- Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016Kidney International, 2018
- An Outcomes-Based Definition of Proteinuria Remission in Focal Segmental GlomerulosclerosisClinical Journal of the American Society of Nephrology, 2017
- Patient-Reported Outcomes in Glomerular DiseaseClinical Journal of the American Society of Nephrology, 2016